Basal and cycle androgen levels correlate with in vitro fertilization stimulation parameters but do not predict pregnancy outcome

Fertility and Sterility

Volumn 86, Issue 1, 2006, Pages 51-57

  Frattarelli, John L ^a   Gerber, Maria D ^a  

^a TRIPLER ARMY MEDICAL CENTER   (United States)

Author keywords

androgens; androstenedione; cancellation rate; clinical outcome; dehydroepiandrosterone sulfate; In vitro fertilization; infertility; pregnancy rate; testosterone

Indexed keywords

ANDROGEN; CHORIONIC GONADOTROPIN; FOLLITROPIN; LUTEINIZING HORMONE; PROSTAGLANDIN E2; TESTOSTERONE;

ADULT; ANDROGEN BLOOD LEVEL; ARTICLE; BODY MASS; COHORT ANALYSIS; CONTROLLED STUDY; EMBRYO; EMBRYO CULTURE; EMBRYO TRANSFER; EVALUATION; FEMALE; FEMALE INFERTILITY; FERTILIZATION IN VITRO; FETUS ECHOGRAPHY; FETUS HEART RATE; GESTATIONAL AGE; HORMONAL REGULATION; HUMAN; HUMAN TISSUE; INTRAUTERINE INSEMINATION; LINEAR REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MEDICAL ASSESSMENT; OOCYTE; OVARY FOLLICLE CELL; OVARY FUNCTION; PREDICTION; PREGNANCY OUTCOME; PREGNANCY RATE; PRIORITY JOURNAL; RADIOIMMUNOASSAY; SEX HORMONE DETERMINATION; TESTOSTERONE BLOOD LEVEL;

ADULT; ANDROGENS; FEMALE; FERTILIZATION IN VITRO; HAWAII; HUMANS; INFERTILITY, FEMALE; MENSTRUAL CYCLE; OUTCOME ASSESSMENT (HEALTH CARE); OVULATION INDUCTION; PREGNANCY; PREGNANCY OUTCOME; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; STATISTICS;

EID: 33745514305     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2005.12.028     Document Type: Article

References (28)

1. Scott R.T., Hofmann G.E., Oehninger S., and Muasher S.J. Intercycle variability of day 3 follicle-stimulating hormone levels and its effect on stimulation quality in in vitro fertilization. Fertil Steril 53 (1990) 297-302
2. Scott R.T., Toner J.F., Muasher S.J., Oehninger S.C., Robinson S., and Rosenwaks Z. Follicle stimulating hormone levels on cycle day 3 are predictive of in vitro fertilization outcome. Fertil Steril 51 (1989) 651-654
3. Navot D., Rosenwaks Z., and Margalioth E.J. Prognostic assessment of female fecundity. Lancet 2 (1987) 645-647
4. Hofmann G.E., Sosnowski J., Scott R.T., and Thie J. Efficacy of selection criteria for ovarian reserve screening using the clomiphene citrate challenge test in a tertiary fertility center population. Fertil Steril 66 (1996) 49-53
5. Loumaye E., Billion J.M., Mine J.M., Psalit I., Pensis M., and Thomas K. Prediction of individual response to controlled ovarian hyperstimulation by means of a clomiphene citrate challenge test. Fertil Steril 53 (1990) 295-301
6. Pearlstone A.C., Fournet N., Gambone J.C., Pang S.C., and Buyalos R.P. Ovulation induction in women age 40 and older. the importance of basal follicle-stimulating hormone level and chronological age. Fertil Steril 58 (1992) 674-679
7. Scott R.T., Toner J.F., Muasher S.J., Oehninger S.C., Robinson S., and Rosenwaks Z. Follicle stimulating hormone levels on cycle day 3 are predictive of in vitro fertilization outcome. Fertil Steril 51 (1989) 651-654
8. Scott R.T., Leonardi M.R., Hofmann G.E., Illions E.H., Neal G.S., and Navot D. A prospective evaluation of clomiphene citrate challenge test screening in the general infertility population. Obstet Gynecol 82 (1993) 539-545
9. Scott R.T., Dellinger C.L., Leonardi M.R., Illions E.H., Hofmann G.E., and Navot D. Evaluation of the significance of a poor estradiol response during the clomiphene citrate challenge test. Fertil Steril 60 (1993) 242-246
10. Scott R.T., Opsahl M.S., Leonardi M.R., Neal G.S., Illions E.H., and Navot D. Life table analysis of pregnancy rates in a general infertility population relative to ovarian reserve and patient age. Hum Reprod 10 (1995) 1706-1710
11. Scott R.T., and Hofmann G.E. Prognostic assessment of ovarian reserve. Fertil Steril 63 (1995) 1-11
12. Frattarelli J.L., Levi A.J., Miller B.T., and Segars J.H. Prognostic use of mean ovarian volume in in vitro fertilization cycles. a prospective assessment. Fertil Steril 82 (2004) 811-815
13. Toner J.P., Philput C.B., Jones G.S., and Muasher S.J. Basal follicle stimulating hormone level is a better predictor of in vitro fertilization performance than age. Fertil Steril 55 (1991) 784-791
14. Klein N.A., Battaglia D.E., Fujimoto V.Y., Davis G.S., Bremmer W.J., and Soules M.R. Reproductive aging. accelerated ovarian follicular development associated with a monotropic follicle-stimulating hormone rise in normal older women. J Clin Endocrinol Metab 81 (1996) 1038-1045
15. Klein N.A., Battaglia D.E., Clifton D.K., Bremner W.J., and Soules M.R. The gonadotropin secretion pattern in normal women of advanced reproductive age in relation to the monotropic FSH rise. J Soc Gynecol Invest 3 (1996) 27-32
16. Frattarelli J.L., Miller B.T., Lauria-Costa D., Bergh P.A., and Scott R.T. Basal antral follicle number and mean ovarian diameter predict cycle cancellation and ovarian responsiveness in assisted reproductive technology cycles. Fertil Steril 74 (2000) 512-517
17. Seifer D.B., Gardiner A.C., Lambert-Messerlian G., and Schneyer A.L. Differential secretion of dimeric inhibin in cultured luteinized granulosa cells as a function of ovarian reserve. J Clin Endocrinol Metab 81 (1996) 736-739
18. Frattarelli J.L., Bergh P.A., Sable D.B., Drews M.R., Sharara F.I., and Scott R.T. Evaluation of the prognostic significance of day 3 estradiol levels in assisted reproductive technology cycles. Fertil Steril 74 (2000) 518-524
19. Licciardi F.L., Liu H.C., and Rosenwaks Z. Day 3 estradiol serum concentrations as prognosticators of ovarian stimulation response and pregnancy outcome in patients undergoing in vitro fertilization. Fertil Steril 64 (1995) 991-994
20. Smotrich D.B., Widra E.A., Gindoff P.R., Levy M.J., Hall J.L., and Stillman R.J. Prognostic value of day 3. estradiol on in vitro fertilization outcome. Fertil Steril 64 (1994) 1136-1140
21. Evers J.L.H., Slaats P., Land J.A., Dumoulin J.C.M., and Dunselman G.A.J. Elevated levels of basal estradiol-17β predict poor response in patients with normal basal levels of follicle-stimulating hormone undergoing in vitro fertilization. Fertil Steril 69 (1998) 1010-1014
22. Frattarelli J.L., Levi A.J., Miller B.T., and Segars J.H. A prospective assessment of the predictive value of basal antral follicles in in vitro fertilization cycles. Fertil Steril 80 (2003) 350-355
23. Ranieri D.M., Quinn F., Makhlouf A., Khadum I., Ghutmi W., McGarrigle H., et al. Simultaneous evaluation of basal follicle stimulating hormone and 17β-estradiol response to gonadotropin-releasing hormone analogue stimulation. an improved predictor of ovarian reserve. Fertil Steril 70 (1998) 227-233
24. Frattarelli J.L., and Peterson E.H. Effect of androgen levels on in vitro fertilization cycles. Fertil Steril 81 (2004) 1713-1714
25. Leondires M.P., Escalpes M., Segars J.H., Scott Jr. R.T., and Miller B.T. Microdose follicular phase gonadoptropin-releasing hormone agonist (GnRH-a) compared with luteal phase GnRH-a for ovarian stimulation at in vitro fertilization. Fertil Steril 72 (1999) 1008-1023
26. Scott R.T., and Navot D. Enhancement of ovarian responsiveness with microdoses of gonadotropin-releasing hormone agonist during ovulation induction for in vitro fertilization. Fertil Steril 61 (1994) 880-885
27. Droesch K., Muasher S.T., Brzyski R., Jones S.G., Simonetti S., Liu H.C.H., et al. Value of suppression with a GnRH-a prior to gonadotropin stimulation for in vitro fertilization. Fertil Steril 51 (1989) 292-295
28. Bammann B.L., Coulam C.B., and Jiang N.-S. Total and free testosterone during pregnancy. Am J Obstet Gynecol 137 (1980) 293-297